1. PrabhuA, ObiKO, RubensteinJH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta‐analysis. Am J Gastroenterol2014;109:822. CrossRef

2. La VecchiaC, LiatiP, DecarliA, et al.Tar yields of cigarettes and the risk of oesophageal cancer. Int J Cancer1986;38:381. CrossRef

3. FranceschiS, TalaminiR, BarraS, et al.Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res1990;50:6502.

4. LeeCH, LeeKW, FangFM, et al.The neoplastic impact of tobacco‐free betel‐quid on the histological type and the anatomical site of aerodigestive tract cancers. Int J Cancer2012;131:E733. CrossRef

5. PoirierMC. Chemical‐induced DNA damage and human cancer risk. Nat Rev Cancer2004;4:630. CrossRef

6. LinK, WuY, ShenW. Interaction of total N‐nitroso compounds in environment and in vivo on risk of esophageal cancer in the coastal area, China. Environ Int2009;35:376. CrossRef

7. CuomoR, AndreozziP, ZitoFP. Alcoholic beverages and carbonated soft drinks: consumption and gastrointestinal cancer risks. Cancer Treat Res2014;159:97. CrossRef

8. HurleyTD, EdenbergHJ. Genes encoding enzymes involved in ethanol metabolism. Alcohol Res2012;34:339.

9. LiuX, WangX, LinS, et al.Dietary patterns and oesophageal squamous cell carcinoma: a systematic review and meta‐analysis. Br J Cancer2014;110:2785. CrossRef

10. QuX, BenQ, JiangY. Consumption of red and processed meat and risk for esophageal squamous cell carcinoma based on a meta‐analysis. Ann Epidemiol2013;23:762. CrossRef

11. XiaoQ, FreedmanND, RenJ, et al.Intakes of folate, methionine, vitamin B6, and vitamin B12 with risk of esophageal and gastric cancer in a large cohort study. Br J Cancer2014;110:1328. CrossRef

12. TangL, LeeAH, XuF, et al.Fruit and vegetable consumption and risk of esophageal cancer: a case‐control study in north‐west China. Dis Esophagus2013. Epub ahead of print.

13. Palladino‐DavisAG, MendezBM, FisichellaPM, et al.Dietary habits and esophageal cancer. Dis Esophagus2013. Epub ahead of print.

14. RaySS, DasD, GhoshT, et al.The levels of zinc and molybdenum in hair and food grain in areas of high and low incidence of esophageal cancer: a comparative study. Glob J Health Sci2012;4:168.

15. BarchDH, KuemmerleSC, HollenbergPF, et al.Esophageal microsomal metabolism of N‐nitrosomethylbenzylamine in the zinc‐deficient rat. Cancer Res1984;44:5629.

16. KrizkovaS, RyvolovaM, HrabetaJ, et al.Metallothioneins and zinc in cancer diagnosis and therapy. Drug Metab Rev2012;44:287. CrossRef

17. VincetiM, DennertG, CrespiCM, et al.Selenium for preventing cancer. Cochrane Database Syst Rev2014;(3):CD005195.

18. SchwarzG, BelaidiAA. Molybdenum in human health and disease. Met Ions Life Sci2013;13:415. CrossRef

19. O'NeillOM, JohnstonBT, ColemanHG. Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol2013;19:5806. CrossRef

20. MeijssenMA, TilanusHW, Van BlankensteinM, et al.Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients. Gut1992;33:155. CrossRef

21. AggestrupS, HolmJC, SørensenHR. Does achalasia predispose to cancer of the esophagus?Chest1992;102:1013. CrossRef

22. RaviK, GenoDM, KatzkaDA. Esophageal cancer screening in achalasia: is there a consensus?Dis Esophagus2014. Epub ahead of print.

23. ChowTL, LeeDT, ChoiCY, et al.Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis. Arch Otolaryngol Head Neck Surg2009;135:882. CrossRef

24. PetitT, GeorgesC, JungGM, et al.Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous‐cell carcinoma. Ann Oncol2001;12:643. CrossRef

25. HongWK, LippmanSM, ItriLM, et al.Prevention of second primary tumors with isotretinoin in squamous‐cell carcinoma of the head and neck. N Engl J Med1990;323:795. CrossRef

26. AshworthMT, NashJR, EllisA, et al.Abnormalities of differentiation and maturation in the oesophageal squamous epithelium of patients with tylosis: morphological features. Histopathology1991;19:303. CrossRef

27. ReisA, KüsterW, EckardtR, et al.Mapping of a gene for epidermolytic palmoplantar keratoderma to the region of the acidic keratin gene cluster at 17q12‐q21. Hum Genet1992;90:113. CrossRef

28. KelsellDP, RiskJM, LeighIM, et al.Close mapping of the focal non‐epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC). Hum Mol Genet1996;5:857. CrossRef

29. IwayaT, MaesawaC, OgasawaraS, et al.Tylosis esophageal cancer locus on chromosome 17q25.1 is commonly deleted in sporadic human esophageal cancer. Gastroenterology1998;114:1206. CrossRef

30. Von BrevernM, HollsteinMC, RiskJM, et al.Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q. Oncogene1998;17:2101. CrossRef

31. BlaydonDC, EtheridgeSL, RiskJM, et al.RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet2012;90:340. CrossRef

32. FékétéF, MosnierH, BelghitiJ, et al.Esophageal cancer after mediastinal irradiation. Dysphagia1994;9:289.

33. OginoT, KatoH, TsukiyamaI, et al.Radiation‐induced carcinoma of the esophagus. Acta Oncol1992;31:475. CrossRef

34. HardefeldtHA, CoxMR, EslickGD. Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta‐analysis. Epidemiol Infect2014;142:1119. CrossRef

35. LuCL, LangHC, LuoJC, et al.Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes Control2010;21:269. CrossRef

36. NapierKJ, ScheererM, MisraS. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol2014;6:112. CrossRef

37. YangPC, DavisS. Incidence of cancer of the esophagus in the US by histologic type. Cancer1988;61:612. CrossRef

38. MahboubiE, KmetJ, CookPJ, et al.Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer1973;28:197. CrossRef

39. SugimachiK, KitamuraK, MatsudaH, et al.Proposed new criteria for early carcinoma of the esophagus. Surg Gynecol Obstet1991;173:303.

40. AgrawalN, JiaoY, BettegowdaC, et al.Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov2012;2:899. CrossRef

41. WangMT, ChenG, AnSJ, et al.Prognostic significance of cyclinD1 amplification and the co‐alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma. Dis Esophagus2012;25:664. CrossRef

42. ZhaoJ, LiL, WeiS, et al.Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta‐analysis. Dis Esophagus2012;25:520. CrossRef

43. BenzenoS, LuF, GuoM, et al.Identification of mutations that disrupt phosphorylation‐dependent nuclear export of cyclin D1. Oncogene2006;25:6291. CrossRef

44. BarbashO, ZamfirovaP, LinDI, et al.Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell2008;14:68. CrossRef

45. NakagawaH, WangTC, ZukerbergL, et al.The targeting of the cyclin D1 oncogene by an Epstein‐Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene1997;14:1185. CrossRef

46. MuellerA, OdzeR, JenkinsTD, et al.A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res1997;57:5542.

47. BassAJ, WatanabeH, MermelCH, et al.SOX2 is an amplified lineage‐survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet2009;41:1238. CrossRef

48. SongY, LiL, OuY, et al.Identification of genomic alterations in oesophageal squamous cell cancer. Nature2014;509:91. CrossRef

49. LiuQ, YanYX, McClureM, et al.MTS‐1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Oncogene1995;10:619.

50. EndersGH, KohJ, MisseroC, et al.p16 inhibition of transformed and primary squamous epithelial cells. Oncogene1996;12:1239.

51. EgashiraA, MoritaM, KakejiY, et al.p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries. Cancer Sci2007;98:1152. CrossRef

52. AndlCD, FargnoliBB, OkawaT, et al.Coordinated functions of E‐cadherin and transforming growth factor beta receptor II in vitro and in vivo. Cancer Res2006;66:9878. CrossRef

53. StairsDB, BayneLJ, RhoadesB, et al.Deletion of p120‐catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell2011;19:470. CrossRef

54. WolfMC, ZehentmayrF, SchmidtM, et al.Treatment strategies for oesophageal cancer – time‐trends and long term outcome data from a large tertiary referral centre. Radiat Oncol2012;7:60. CrossRef

55. YangCS. Research on esophageal cancer in China: a review. Cancer Res1980;40:2633.

56. GuanreiY, SongliangQ, HeH, et al.Natural history of early esophageal squamous carcinoma and early adenocarcinoma of the gastric cardia in the People's Republic of China. Endoscopy1988;20:95. CrossRef

57. TakeshitaK, MurataS, MitsufujiS, et al.Clinicopathological characteristics of esophageal squamous papillomas in Japanese patients–with comparison of findings from Western countries. Acta Histochem Cytochem2006;39:23. CrossRef

58. SyrjänenK, SyrjänenS. Detection of human papillomavirus in esophageal papillomas: systematic review and meta‐analysis. APMIS2013;121:363. CrossRef

59. DonnellanF, WalkerB, EnnsR. Esophageal papillomatosis complicated by squamous cell carcinoma. Endoscopy2012;44(Suppl 2 UCTN):E110. CrossRef

60. ChinoO, KijimaH, ShimadaH, et al.Clinicopathological studies of esophageal carcinosarcoma: analyses of its morphological characteristics using endoscopic, histological, and immunohistochemical procedures. Endoscopy2000;32:706. CrossRef

61. LauwersGY, GrantLD, ScottGV, et al.Spindle cell squamous carcinoma of the esophagus: analysis of ploidy and tumor proliferative activity in a series of 13 cases. Hum Pathol1998;29:863. CrossRef

62. NaS, ChoiKD, YooC, et al.Verrucous carcinoma of the esophagus. Gastrointest Endosc2009;70:803. CrossRef

63. ChenSB, WengHR, WangG, et al.Primary adenosquamous carcinoma of the esophagus. World J Gastroenterol2013;19:8382. CrossRef

64. TeradaT. Primary combined adenoid cystic carcinoma, basaloid squamous cell carcinoma, and squamous cell carcinoma of the esophagus. Endoscopy2012;44(Suppl 2 UCTN):E102. CrossRef

65. YonalO, IbrisimD, SongurY, et al.Primary malignant melanoma of the esophagus. Case Rep Gastroenterol2013;7:272. CrossRef

66. AhnJY, HwangHS, ParkYS, et al.Endoscopic and pathologic findings associated with clinical outcomes of melanoma in the upper gastrointestinal tract. Ann Surg Oncol2014;21:2532. CrossRef

67. ChenWW, WangF, ChenS, et al.Detailed analysis of prognostic factors in primary esophageal small cell carcinoma. Ann Thorac Surg2014;97:1975. CrossRef

68. LimCS, ParkSJ, ParkMI, et al.Successful endoscopic mucosal resection of a low esophageal carcinoid tumor. Clin Endosc2013;46:576. CrossRef

69. MerimskyO, JossiphovJ, AsnaN, et al.Choriocarcinoma arising in a squamous cell carcinoma of the esophagus. Am J Clin Oncol2000;23:203. CrossRef

70. JiangW, RiceTW, GoldblumJR. Esophageal leiomyoma: experience from a single institution. Dis Esophagus2013;26:167. CrossRef

71. ChenWS, ZhengXL, JinL, et al.Novel diagnosis and treatment of esophageal granular cell tumor: report of 14 cases and review of the literature. Ann Thorac Surg2014;97:296. CrossRef

72. MishraPK, GoelN, SalujaSS, et al.Management of giant fibrovascular polyp of esophagus. Am Surg2012;78:E538.

73. WonJW, LeeHW, YoonKH, et al.Extended hemangioma from pharynx to esophagus that could be misdiagnosed as an esophageal varix on endoscopy. Dig Endosc2013;25:626. CrossRef

74. BestSR, CoelhoDH, AhrensWA, et al.Laser excision of multiple esophageal lymphangiomas: a case report and review of the literature. Auris Nasus Larynx2008;35:300. CrossRef

75. KafeelM, CheedellaNK, WangJC. Esophageal gastrointestinal stromal tumors presenting as mediastinal mass. Case Rep Oncol2013;6:579. CrossRef

76. ZhangBH, ZhangHT, WangYG. Esophageal leiomyosarcoma: clinical analysis and surgical treatment of 12 cases. Dis Esophagus2012;27:547. CrossRef

77. ShiozakiH, TaharaH, KobayashiK, et al.Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer1990;66:2068. CrossRef

78. Bird‐LiebermanEL, NevesAA, Lao‐SirieixP, et al.Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus. Nat Med2012;18:315. CrossRef

79. ShimizuM, ZaninottoG, NagataK, et al.Esophageal squamous cell carcinoma with special reference to its early stage. Best Pract Res Clin Gastroenterol2013;27:171. CrossRef

80. JungJI, KimGH, IH, et al.Clinicopathologic factors influencing the accuracy of EUS for superficial esophageal carcinoma. World J Gastroenterol2014;20:6322. CrossRef

81. EloubeidiMA, WallaceMB, ReedCE, et al.The utility of EUS and EUS‐guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single‐center experience. Gastrointest Endosc2001;54:714. CrossRef

82. SaikanoA, YanaiH, SakaguchiE, et al.Clinical impact of tumor invasion depth staging of esophageal squamous cell carcinoma using EUS. Hepatogastroenterology2010;57:1423.

83. AbdelsalamM, BazarbashiS, AbouziedM, et al.Whole body 18F‐FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial. Hematol Oncol Stem Cell Ther2010;3:179. CrossRef

84. FlamenP, LerutA, Van CutsemE, et al.Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol2000;18:3202.

85. ChaoKS. 3'‐deoxy‐3'‐(18)F‐fluorothymidine (FLT) positron emission tomography for early prediction of response to chemoradiotherapy–a clinical application model of esophageal cancer. Semin Oncol2007;34:S31. CrossRef

86. SEER Stat Fact Sheets: Esophageal Cancer. http://seer.cancer.gov/statfacts/html/esoph/html. Accessed October 2014.

87. ShridharR, Imani‐ShikhabadiR, DavisB, et al.Curative treatment of esophageal cancer; an evidenced based review. J Gastrointest Cancer2013;44:375. CrossRef

88. LindnerK, FritzM, HaaneC, et al.Postoperative complications do not affect long‐term outcome in esophageal cancer patients. World J Surg2014;38:2652. CrossRef

89. LowDE. Evolution in surgical management of esophageal cancer. Dig Dis2013;31:21. CrossRef

90. LinJ, IannettoniMD. Transhiatal esophagectomy. Surg Clin North Am2005;85:593. CrossRef

91. D'JournoXB, ThomasPA. Current management of esophageal cancer. J Thorac Dis2014;6:S253.

92. CooperJS, GuoMD, HerskovicA, et al.Chemoradiotherapy of locally advanced esophageal cancer: long‐term follow‐up of a prospective randomized trial (RTOG 85‐01). Radiation Therapy Oncology Group. JAMA1999;281:1623. CrossRef

93. HomsMY, SteyerbergEW, EijkenboomWM, et al.Single‐dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet2004;364:1497. CrossRef

94. FokM, ShamJS, ChoyD, et al.Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery1993;113:138.

95. BleibergH, ConroyT, PaillotB, et al.Randomised phase II study of cisplatin and 5‐fluorouracil (5‐FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer1997;33:1216. CrossRef

96. GirlingDJ, StewartLA, ParmarMK. Preoperative radiotherapy in the treatment of cancer of the oesophagus. The Medical Research Council Oesophageal Cancer Working Party. Eur J Cancer1992;28A:1003. CrossRef

97. AndoN, IizukaT, KakegawaT, et al.A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg1997;114:205. CrossRef

98. CunninghamD, AllumWH, StenningSP, et al.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med2006;355:11. CrossRef

99. GebskiV, BurmeisterB, SmithersBM, et al.Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta‐analysis. Lancet Oncol2007;8:226. CrossRef

100. CoiaLR. Chemoradiation: a superior alternative for the primary management of esophageal carcinoma. Semin Radiat Oncol1994;4:157. CrossRef

101. MinskyBD, PajakTF, GinsbergRJ, et al.INT 0123 (Radiation Therapy Oncology Group 94‐05) phase III trial of combined‐modality therapy for esophageal cancer: high‐dose versus standard‐dose radiation therapy. J Clin Oncol2002;20:1167. CrossRef

102. Van HagenP, HulshofMC, Van LanschotJJ, et al.Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med2012;366:2074. CrossRef

103. TepperJ, KrasnaMJ, NiedzwieckiD, et al.Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol2008;26:1086. CrossRef

104. AndoN, KatoH, IgakiH, et al.A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5‐fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol2012;19:68. CrossRef

105. JavleM, AilawadhiS, YangGY, et al.Palliation of malignant dysphagia in esophageal cancer: a literature‐based review. J Support Oncol2006;4:365.

106. CunninghamD, StarlingN, RaoS, et al.Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med2008;358:36. CrossRef

107. RaoS, StarlingN, CunninghamD, et al.Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first‐line treatment in patients with advanced oesophago‐gastric cancer: a randomised, multicentre open‐label phase II study. Ann Oncol2010;21:2213. CrossRef

108. Prognostic significance of CyclinD1 and E‐Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg2001;192:708. CrossRef

109. ShimadaH, TakedaA, NabeyaY, et al.Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma. Cancer2001;92:663. CrossRef

110. GuillemP, TribouletJP. Elevated serum levels of C‐reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus2005;18:146. CrossRef

111. SturmI, PetrowskyH, VolzR, et al.Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis. J Clin Oncol2001;19:2272.

112. GuanreiY, HeH, SungliangQ, et al.Endoscopic diagnosis of 115 cases of early esophageal carcinoma. Endoscopy1982;14:157. CrossRef

113. HeresbachD, LerayE, D'HalluinPN, et al.Diagnostic accuracy of esophageal capsule endoscopy versus conventional upper digestive endoscopy for suspected esophageal squamous cell carcinoma. Endoscopy2010;42:93. CrossRef